<!DOCTYPE html>
<html lang="en">
<partial title="Our Business - Vaccines" name="head.html"></partial>

<body>
  <partial name="header.html" />
  <section class="md:h-500 h-36 px-4 md:px-8 lg:px-0 w-full flex items-center" style="
        background-image: url('./assets/images/ourbusiness-vaccine.png');
        background-size: cover;
      ">
    <div class="container max-w-wrapper mx-auto">
      <div>
        <h1 class="
              uppercase
              tracking-heading
              text-xl
              font-semibold
              text-white
              md:mb-3.5
            ">
          our business
        </h1>
        <div class="redStrip h-xs md:h-2 w-20"></div>
        <h2 class="
              font-semibold
              text-white text-xl
              md:text-54 md:leading-81
              tracking-tight
            ">
          Vaccines
        </h2>
      </div>
    </div>
  </section>
  <section class="py-10 md:py-20 lg:py-40 mb-10 ld:mb-0 lg:pb-40">
    <div class="lg:flex">
      <div class="lg:w-1/2 h-auto lg:h-700 rounded-lg overflow-hidden" style="
            background-image: url('./assets/images/biologics/6.png');
            background-size: cover;
          "></div>
      <div class="lg:w-2/3 redStrip relative lg:my-12 lg:rounded-xl lg:-ml-20">
        <div class="text-white 2xl:w-4/5 px-4 lg:px-16 py-10 lg:py-14">
          <h2 style="line-height: 48px" class="my-10 lg:my-5 h2 text-3xl text-white">
            The Indian subsidiary of Emcure Pharmaceuticals, Gennova
            Biopharmaceuticals Ltd is also a leader in developing in-house
            mRNA platform that is engaged in the creation of vaccines and
            other bio-therapeutics.
          </h2>
          <p class="leading-25 lg:leading-30">
            Gennova is India’s only company to deploy the mRNA platform to
            develop a vaccine, HGC019, against the novel coronavirus. HGC019
            has already demonstrated safety, immunogenicity and neutralization
            antibody activity in rodents and non-human primate models. Further
            to its animal toxicity studies, Gennova is now gearing up to take
            the vaccine to the next step of clinical study. Apart from this,
            Gennova is also using the mRNA platform to create vaccines against
            Zika, rabies and Zoster which are in the pre-clinical stage.
          </p>
        </div>
      </div>
    </div>
  </section>
  <section class="redStrip px-4 md:px-8 w-full lg:h-80 py-12">
    <div class="max-w-wrapper mx-auto">
      <div class="md:flex text-white">
        <div class="md:w-1/3">
          <div class="md:flex">
            <img class="self-center mx-4" src="./assets/images/mrna.png" alt="" />
            <p class="h2 text-white">What are mRNA vaccines?</p>
          </div>
        </div>
        <div class="md:w-2/3 my-14 md:my-0 md:mb-10 md:px-10">
          <p>
            In a standard viral vaccine, either inactivated (or attenuated)
            virus or viral proteins known to cause the infection are used for
            immunization. However, an mRNA vaccine carries the molecular
            instructions to make the protein in the body through a synthetic
            RNA of the virus. The host body uses this to produce the viral
            protein that is recognized by the immune system, thereby making
            the body ready to fight against the disease.
          </p>
        </div>
      </div>
    </div>
  </section>
  <section class="-mt-20 lg:-mt-32 px-2 lg:px-0">
    <div class="container max-w-wrapper mx-auto mb-10 lg:mb-40">
      <div class="lg:mx-24">
        <div class="
              bg-white
              rounded-xl
              border border-gray-100
              transition-all
              duration-100
              shadow-transparent shadow-2xl
              overflow-hidden
              px-8
              lg:px-14
              py-8
              my-4 my-10
            ">
          <div class="dropdown opened">
            <h2 class="h2 lg:text-3xl mb-7">
              What are the advantages of mRNA vaccines?
            </h2>
            <svg xmlns="http://www.w3.org/2000/svg" class="h-6 w-6" fill="none" viewBox="0 0 24 24"
              stroke="currentColor">
              <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M19 9l-7 7-7-7" />
            </svg>
          </div>
          <div class="transition-all duration-100 ease-linear">
            <img class="mb-5" src="./assets/images/ourbusiness-vaccine-1.jpg" alt="" />
            <ul class="">
              <li class="red-dot mb-4 text-primary-body">
                Novel vaccine development can take anywhere between 10 – 15
                years. Considering the immediate need for a vaccine against
                COVID 19, the developmental time for the vaccine is critical.
                mRNA vaccines are thus, the ideal choice given their rapid
                developmental timeline
              </li>
              <li class="red-dot mb-4 text-primary-body">
                mRNA vaccines are considered safe as the mRNA is
                non-infectious, non-integrating in nature and degraded by
                normal cellular mechanisms. They are highly efficacious
                because of their inherent capability of being translatable
                into the protein structure inside the cell cytoplasm
              </li>
              <li class="red-dot mb-4 text-primary-body">
                Additionally, mRNA vaccines are fully synthetic and do not
                require a host for growth, example eggs or bacteria.
                Therefore, they have a shorter manufacturing lead time
              </li>
            </ul>
          </div>
        </div>
        <div class="my-2 h-px bg-primary-light bg-opacity-30"></div>
        <div class="
              bg-white
              rounded-xl
              border border-gray-100
              transition-all
              duration-100
              shadow-transparent
              h-28
              overflow-hidden
              px-8
              lg:px-14
              py-8
              my-4
            ">
          <div class="dropdown">
            <h2 class="h2 lg:text-3xl mb-7">
              How does the mRNA vaccine, HGCO19, work against the coronavirus?
            </h2>
            <svg xmlns="http://www.w3.org/2000/svg" class="h-6 w-6" fill="none" viewBox="0 0 24 24"
              stroke="currentColor">
              <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M19 9l-7 7-7-7" />
            </svg>
          </div>
          <div class="transition-all duration-100 ease-linear opacity-0">
            <img class="mb-5" src="./assets/images/ourbusiness-vaccine-2.jpg" alt="" />
            <ul class="">
              <li class="red-dot mb-4 text-primary-body">
                The novel mRNA vaccine candidate, HGC019, has all the
                necessary information to guide the host cells to make the
                antigen – spike protein of the virus, reported to interact
                with host cells receptor, and supported by ‘lipid inorganic
                nanoparticle (LION™)’ as a delivery vehicle
              </li>
              <li class="red-dot mb-4 text-primary-body">
                When the vaccine is injected into the body the synthetic mRNA
                is taken to muscle cells where it instructs the cells to make
                numerous copies of the mRNA and antigen
              </li>
              <li class="red-dot mb-4 text-primary-body">
                The coronavirus also uses its RNA genome guided approach to
                multiply and express viral proteins within the human body
                cells. Hence, Gennova’s approach which is similar to this
                action, gives it an advantage over other vaccine candidates to
                present the identically folded form of spike protein of
                coronavirus as it is reported during its infection cycle
              </li>
              <li class="red-dot mb-4 text-primary-body">
                Other immune cells then act on the spike proteins and in the
                process learn to identify the coronavirus and protect the body
                if the person were ever to be actually infected
              </li>
              <li class="red-dot mb-4 text-primary-body">
                The mRNA is associated with the ‘lipid inorganic nanoparticle
                (LION™) and acts as mRNA vaccine delivery system’ which
                stabilizes the mRNA and acts as adjuvant till delivery into
                patients
              </li>
            </ul>
          </div>
        </div>
        <div class="my-2 h-px bg-primary-light bg-opacity-30"></div>

        <div class="
              bg-white
              rounded-xl
              border border-gray-100
              transition-all
              duration-100
              shadow-transparent
              h-28
              overflow-hidden
              px-8
              lg:px-14
              py-8
              my-4
            ">
          <div class="dropdown">
            <h2 class="h2 lg:text-3xl mb-7">
              What makes HGCO19 a unique vaccine candidate against COVID- 19?
            </h2>
            <svg xmlns="http://www.w3.org/2000/svg" class="h-6 w-6" fill="none" viewBox="0 0 24 24"
              stroke="currentColor">
              <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M19 9l-7 7-7-7" />
            </svg>
          </div>
          <div class="transition-all duration-100 ease-linear opacity-0">
            <img class="mb-5" src="./assets/images/ourbusiness-vaccine-3.jpg" alt="" />
            <ul class="">
              <li class="red-dot mb-4 text-primary-body">
                HGCO19 uses the self-amplifying mRNA platform which gives it
                the advantage of a low dosing regimen
              </li>
              <li class="red-dot mb-4 text-primary-body">
                HGCO19 is stable at 2-8°C
              </li>
            </ul>
          </div>
        </div>
      </div>
    </div>
  </section>
  <!-- Our Business Footer -->
  <partial name="redstrip-section.html" title="Know More About Our Offerings" css-prev="myswiper-button-prev"
    css-next="myswiper-button-next" />
  <section class="-mt-20">
    <div class="w-full h-350 overflow-hidden swiper-container mySwiper2">
      <div class="flex swiper-wrapper">
        <partial name="slider/slide-square.html" image="./assets/images/offering/3.png" title="Formulation" />
        <partial name="slider/slide-square.html" image="./assets/images/offering/1.png"
          title="Indian Pharmaceutical Market" />
        <partial name="slider/slide-square.html" image="./assets/images/offering/1.png"
          title=" International Presence" />
        <partial name="slider/slide-square.html" image="./assets/images/offering/2.png" title="Biologics" />
        <partial name="slider/slide-square.html" image="./assets/images/api.png" title="API's" />
        <partial name="slider/slide-square.html" image="./assets/images/vaccine.png" title="Overview" />
      </div>
    </div>
  </section>
  <div class="md:h-20"></div>
  <partial name="redstrip-section.html" title="Quick Explore" css-prev="myswiper2-button-prev"
    css-next="myswiper2-button-next" />
  <section class="-mt-20">
    <div class="w-full h-350 overflow-hidden swiper-container mySwiper2">
      <div class="flex swiper-wrapper">
        <partial name="slider/slide-square.html" image="./assets/images/aboutus/4.png" title="About us" />
        <partial name="slider/slide-square.html" image="./assets/images/aboutus/1.png" title="Research" />
        <partial name="slider/slide-square.html" image="./assets/images/aboutus/2.png" title="Careers" />

      </div>
    </div>
  </section>
  <div class="md:h-20"></div>
  <partial name="footer.html" />

  <script src="https://unpkg.com/swiper/swiper-bundle.min.js"></script>
  <script src="https://unpkg.com/scrollreveal"></script>
  <script src="./script.js"></script>
  <script>
    const toggleMenu = () => {
      document.getElementById("menu").classList.toggle("hidden");
    };
    allMenuItems = document.querySelectorAll("#menu li");
    allMenuItems.forEach((item) => {
      if (item.firstElementChild) {
        item.addEventListener("click", () => {
          item.firstElementChild.classList.toggle("hidden");
        });
      }
    });
    window.onload = (event) => {
      var swipera = new Swiper(".mySwiper", {
        spaceBetween: 30,
        slidesPerView: "auto",
        autoplay: {
          delay: 3000,
        },
        loop: true,
        navigation: {
          nextEl: ".myswiper-button-next",
          prevEl: ".myswiper-button-prev",
        },
      });
      var swiperb = new Swiper(".mySwiper2", {
        spaceBetween: 30,
        slidesPerView: "auto",
        autoplay: {
          delay: 3000,
        },
        loop: true,
        navigation: {
          nextEl: ".myswiper2-button-next",
          prevEl: ".myswiper2-button-prev",
        },
      });
      const expandables = document.querySelectorAll(".dropdown");
      expandables.forEach((expandable) => {
        expandable.parentElement.style.minHeight =
          expandable.offsetHeight + 32 + "px";
        expandable.addEventListener("click", () => {
          expandable.parentElement.classList.toggle("h-28");

          expandable.parentElement.classList.toggle("shadow-2xl");
          expandable.parentElement.classList.toggle("my-10");
          expandable.nextElementSibling.classList.toggle("opacity-0");

          expandable.classList.toggle("opened");
        });
      });
    };
  </script>
</body>

</html>